MedCity News
SEPTEMBER 1, 2022
An upcoming webinar sponsored by Huma will highlight three aspects of remote monitoring: real world data collection, supercharging patient engagement and navigating the regulatory landscape. Register today!
PharmaVoice
SEPTEMBER 1, 2022
A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 1, 2022
More people are turning to health solutions like Cognitive Behavioral Therapy and Internet-based Cognitive Behavioral Therapy (iCBT) to help minimize the negative mental health impact many are currently facing.
pharmaphorum
SEPTEMBER 1, 2022
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
SEPTEMBER 1, 2022
Jennifer Gentile of Boston Children’s Hospital offered her perspective on digital health tools addressing mental health needs with the goal of reducing reliance on drugs, in a preview of the INVEST Digital Health conference in Dallas on September 20.
pharmaphorum
SEPTEMBER 1, 2022
AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London. Chris Sheldon ended an almost 19-year career at AZ in August, working his way up from a lab role and holding a series of senior positions at the company, most recently as head of investor relations.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Map My Customers
SEPTEMBER 1, 2022
Sales can be a very rewarding profession, but also a tricky one. In order to be successful as an outside sales rep it is important to do your research on the latest sales statistics. Thankfully, research has taken a lot of the mystery out of sales, so you do not depend on trial and error when trying to find a method that works. Having a good understanding of current sales statistics and market trends will help build the foundation to begin to really define and understand your audience.
MedCity News
SEPTEMBER 1, 2022
The new feature allows users to see their cholesterol trends over time. They can input their readings from clinics and labs in one place, schedule appointments and receive digital coaching to make improvements.
Pharmaceutical Technology
SEPTEMBER 1, 2022
Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Under the collaboration, the companies will use the GuardantINFORM real-world evidence (RWE) platform to boost works for developing Merck’s precision cancer pipeline. The development of therapies for key oncology indications with substantial unmet needs will be the expanded partnership’s focus.
pharmaphorum
SEPTEMBER 1, 2022
Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive Fiona Marshall. Novartis said this morning that Bradner (pictured above left) – who is also stepping down from the executive committee – is leaving to “pursue a next chapter of scientific contribution and leadership” outside the company.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTimes
SEPTEMBER 1, 2022
Fourth award from the Bill & Melinda Gates Foundation will support artemisinin research
PharmExec
SEPTEMBER 1, 2022
In episode 116, Dr. Greg Rippon, vice president and chief medical partner at Genentech, discusses his work in Alzheimer’s and his outlook for the future of the therapeutic space.
PharmaTimes
SEPTEMBER 1, 2022
Pro-doxorubicin will advance to the fourth dose following a positive review of safety and tolerability
PharmaVoice
SEPTEMBER 1, 2022
Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
SEPTEMBER 1, 2022
Analysts at GlobalData predict that the market for point-of-care (POC) diagnostic devices will reach $297.6bn by 2023, a growth of almost $1bn from 2015. While a significant proportion of this increase is due to the volume of lateral flow tests (LFTs) manufactured to perform mass screening of populations for Covid-19 over the last two years, this trend towards POC diagnostics is positive news.
pharmaphorum
SEPTEMBER 1, 2022
Mia Ekdahl, head of relations and communications at Health Works, an AstraZeneca division, joins pharmaphorum Editor-in-Chief Jonah Comstock to discuss the work her team is doing to approach healthcare problem-solving in a novel, patient-centric way. Too often digital health efforts find themselves in the unfortunate position of being solutions in search of a problem, with a company or health system so invested in a particular technology or modality it loses sight of the holistic, complex nature
MedTechVets
SEPTEMBER 1, 2022
SEPTEMBER 1 – On August 23rd, MedTechVets held its Summer Networking Conference to mark the end of our Summer Academy. This conference, we were lucky to be joined by 42 individuals, always with the same goal–to build a bridge to help military veterans successfully transition to meaningful civilian careers. “ It’s great to feel supported on your journey”. – Shawn Tillman, Summer 2022 fellow.
Copyright Clearance Center
SEPTEMBER 1, 2022
September 1, 2022 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced the appointment of David Foster as Chairman of its Board of Directors. “As a member of our Board of Directors for 17 years, David has played a huge part in guiding CCC as we expanded our portfolio of solutions, advanced a pro-copyright agenda, and grew rightsholder royalties,” said Tracey Armstrong, President and CEO, CCC.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
SEPTEMBER 1, 2022
Buildings vacated at the peak of Covid-19 are subject to greater risks of water stagnation due to a lack of flow and activity. Even if buildings have been reopened for some time, there may be unresolved risks within water systems. Returning occupants are at risk of exposure to harmful bacteria. From hospitals and hotels to offices and gyms, water stagnation must be mitigated wherever water may be directly consumed or used for washing.
eMediWrite
SEPTEMBER 1, 2022
1. COLLECT INFORMATION FROM MULTIPLE SOURCES. Knowing your target market should be the first step in any marketing strategy. This is now achievable with unmatched accuracy thanks to technological advancements. To enhance digital marketing, pharmaceutical businesses should also make advantage of user data. People use search engines to look for conditions and products, adding keywords that you may look up and analyse.
pharmaphorum
SEPTEMBER 1, 2022
Sanofi now has approval on both sides of the Atlantic for Xenpozyme – its enzyme replacement therapy for rare disease acid sphingomyelinase deficiency (ASMD) – after getting a green light from the US FDA. Xenpozyme (olipudase alfa) the first and only approved therapy for ASMD, a group of genetic disorders also known as Niemann-Pick disease, in which a fatty substance called sphingomyelin builds up in cells and caused them to die, disrupting tissue and organ function.
Pharmacy Times
SEPTEMBER 1, 2022
Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaTech
SEPTEMBER 1, 2022
A Post Approval Change (PAC) in size of thermal shipping solution used for transport of product is considered a low risk provided it has been qualified and temperature monitored, and therefore can be downgraded from a prior approval to a notification to health authorities, and managed in the PQS with immediate implementation effect.
Pharmacy Times
SEPTEMBER 1, 2022
Though around 42% of medical students in study experience headaches, many of these causing significant functional disability, most choose to self-manage symptoms with sleep and medication.
Progressive Medical
SEPTEMBER 1, 2022
You must be a registered user to view this information. The post Monthly Employee Portal Updates | August 2022 appeared first on Progressive Medical, Inc.
Pharmacy Times
SEPTEMBER 1, 2022
An overview of the legal and business tools available to community, specialty, hospital, and health-system pharmacies in seeking to maintain payer network access and combat abusive practices.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Commerce
SEPTEMBER 1, 2022
Location expands company’s pharmacovigilance, regulatory affairs services.
Pharmacy Times
SEPTEMBER 1, 2022
Study results show that the risk of gaining 10% or more of body weight from the baseline fell 50% when patients were on the combination.
pharmaphorum
SEPTEMBER 1, 2022
UK medtech company Brainomix has claimed its first national contract – from Hungary – for its artificial intelligence-based platform used to improve diagnosis and treatment of people with suspected stroke from medical images. The platform – called e-Stroke – is already deployed in hundreds of hospitals across the UK, other countries in Europe and Asia as well as the US but this is the first time that it has been the subject of a nationwide tender, according to the Oxford-based company.
Pharmacy Times
SEPTEMBER 1, 2022
Georgia State University analysis supports new strategy for creating these vaccines, investigators contend.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
125 
Let's personalize your content